Table 1: Demographics and outcomes based on highest D-dimer levels of a random sample of inpatients at Northern New York City Hospital during height of COVID-19 Pandemic.
|
D dimer levels (ug/mL FEU) |
< 1 |
1 to 9.9 |
10-19.9 |
> 20 |
Total |
|
# of patients |
13 |
17 |
19 |
23 |
72 |
|
Average age |
62 (26-90) |
64 (31-92) |
71 (43-92) |
72 (39-93) |
68 (26-93) |
|
Male gender |
6/13 (46%) |
10/17(59%) |
10/19 (53%) |
12/23 (52%) |
38/72 (53%) |
|
Consolidation |
11/13 (85%) |
16/17 (94%) |
19/19 (100%) |
23/23 (100%) |
69/72 (96%) |
|
Diabetes |
4/13 (31%) |
4/17 (24%) |
14/19 (74%) |
17/23 (74%) |
39/72 (54%) |
|
Hypertension |
9/13 (69%) |
11/17 (65%) |
16/19 (84%) |
19/23 (83%) |
55/72 (76%) |
|
Average D-dimer (ug/mL FEU) |
0.59 (0.3-0.98) |
2.5 (1.12-7.72) |
15.3 (10.0-19.9) |
20 |
11.1 (0.3-20) |
|
Troponin (ng/L) |
60 (6-544) |
82 (6-284) |
229 (7-2642) |
261 (27-2223) |
174 (6-2642) |
|
Creatinine max (mg/dl) |
1.3 (1-3) |
2.4 (0.7-9.9) |
2.8 (0.6-10.7) |
3.4 (0.6-7.3) |
2.6 (0.6-10.7) |
|
Death |
1/13 (8%) |
6/17 (35%) |
5/19 (26%) |
12/23 (52%) |
24/72 (33%) |
|
Ongoing hospitalization |
0/13 (0%) |
1/17 (6%) |
5/19 (26%) |
11/23 (48%) |
17/72 (24%) |
|
Discharge |
12/13 (92%) |
10/17 (59%) |
9/19 (47%) |
0/23 (0%) |
31/72 (43%) |
|
Intubation |
0/13 (0%) |
5/17 (29%) |
9/19 (47%) |
17/23 (74%) |
31/72 (43%) |
|
Heparin full dose |
0/13 (0%) |
3/17 (18%) |
4/19 (21%) |
11/23 (48%) |
18/72 (25%) |
|
SQ heparin |
1/13 (8%) |
3/17 (18%) |
4/19 (21%) |
4/23 (17%) |
12/72 (17%) |
|
Enoxaparin |
12/13 (92%) |
9/17 (53%) |
9/19 (47%) |
6/23 (26%) |
36/72 (50%) |
|
Hydroxychloroquine |
6/13 (46%) |
13/17 (76%) |
15/19 (79%) |
18/23 (78%) |
52/72 (72%) |